Acadia Pharmaceuticals (ACAD) EPS (Diluted) (2010 - 2026)
Acadia Pharmaceuticals (ACAD) posted EPS (Diluted) of $0.18 for Q2 2026, up 15.3% from $0.16 a year earlier and up 765.4% from the prior quarter.
Powered by 
Analysis
Acadia Pharmaceuticals (ACAD) EPS (Diluted) (2010 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, EPS (Diluted) at Acadia Pharmaceuticals was $2.20, up 67.1% year-over-year; for FY2025, it came in at $2.30, up 69.0% from FY2024.
- In prior years, Acadia Pharmaceuticals' EPS (Diluted) was $1.36 in FY2024, -$0.37 in FY2023, -$1.34 in FY2022 and -$1.05 in FY2021.
- Quarterly EPS (Diluted) has run from a low of -$0.70 in Q1 2022 to a high of $1.61 in Q4 2025 over five years.
- On a year-over-year basis, EPS (Diluted) increased in five of the last seven quarters, with growth averaging 47.9%.
- According to Business Quant data, EPS (Diluted) for the three prior quarters was $0.02 (Q1 2026), $1.61 (Q4 2025) and $0.42 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 7.94 |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 2.27 |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 2.04 |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | -0.54 |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 1.67 |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 1.60 |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 4.37 |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | -8.44 |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | -0.04 |
| 10 | Acadia Pharmaceuticals | 3.47 Bn | -4.91 Mn | 279.64 Mn | 0.18 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 0.18 |
| Mar 31, 2026 | 0.02 |
| Dec 31, 2025 | 1.61 |
| Sep 30, 2025 | 0.42 |
| Jun 30, 2025 | 0.16 |
| Mar 31, 2025 | 0.11 |
| Dec 31, 2024 | 0.86 |
| Sep 30, 2024 | 0.20 |
| Jun 30, 2024 | 0.20 |
| Mar 31, 2024 | 0.10 |
| Dec 31, 2023 | 0.28 |
| Sep 30, 2023 | -0.40 |
| Jun 30, 2023 | 0.01 |
| Mar 31, 2023 | -0.27 |
| Dec 31, 2022 | -0.26 |
| Sep 30, 2022 | -0.17 |
| Jun 30, 2022 | -0.21 |
| Mar 31, 2022 | -0.70 |
| Dec 31, 2021 | -0.27 |
| Sep 30, 2021 | -0.09 |
API Access
Acadia Pharmaceuticals EPS (Diluted) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=eps-diluted&ticker=ACAD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "eps-diluted", "ticker": "ACAD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=eps-diluted&ticker=ACAD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();